R&D Nine for 2024, Pt 2: Phase change and the challenges of scal... In the first segment of Nine for 2024, we examined the continued fragility of healthcare systems, global pharmaceutical market infrastructure, and the journey to greater resilience.
Sales & Marketing Sponsored Top 5 pharma marketing trends in 2024 2023 was a year of many innovations and changes.
Sales & Marketing Life sciences marketing ahead: Unveiling the role of AI-powe... The life sciences, just like any other industry, has been undergoing a paradigm shift, owing to rising digital adoption in the past few years.
Sales & Marketing Sponsored 12 Questions with Marcus West Marcus West grew up in a family of educators. His mother is a historian and his father a headmaster.
Sales & Marketing Navigating the path to sustainable pharma: Insights from sus... In the dynamic landscape of life sciences, the importance of Environmental, Social, and Governance (ESG) considerations has never been more evident.
Sales & Marketing Following these best practices while coding helps providers ... Medical billing errors are a costly problem for the healthcare industry.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.